RAB26 identified as a critical regulator of prostate cancer aggressiveness

Teona Gherasim

Compuscript Ltd Sep 11 2025 Prostate cancer (PCa) is one of the most common malignant tumors in men worldwide. While early detection has improved patient outcomes, effective therapies for advanced disease remain limited. Identifying the molecular drivers of PCa growth and metastasis is therefore essential to developing new treatment strategies that can overcome resistance to standard therapies. In a recent study published in Genes & Diseases , researchers from Chongqing Medical University,

RAB26 identified as a critical regulator of prostate cancer aggressiveness https://www.news-medical.net - 11.09.2025 18:45

din zilele anterioare

RAB26 identified as a critical regulator of prostate cancer aggressiveness https://www.news-medical.net - 11.09.2025 18:45